Related Experiment Video
Updated: May 1, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Model predictive control for optimally scheduling intermittent androgen suppression of prostate cancer
Yoshito Hirata1, Shun-ichi Azuma2, Kazuyuki Aihara1
1Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.
Abstract:
Mathematical modeling of prostate cancer under intermittent androgen suppression revealed that we may be able to delay relapse by optimally scheduling the hormone therapy for each patient. However, our previous study showed the difficulty of the scheduling by minimizing the maximal tumor growth rate because the transient dynamics is also important and can help to delay the relapse for a finite time. Here, we propose to use model predictive control for scheduling intermittent androgen suppression. We find that model predictive control tends to delay the relapse of prostate specific antigen more than the method with minimizing the maximal tumor growth rate. Therefore, model predictive control is a promising approach for practically applying the mathematical model to optimally schedule intermittent androgen suppression.
Related Concept Videos
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Dosage Regimens: Partial Pharmacokinetic Parameters

